ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,969Medicare Part D Prescriptions Filled, Including Refills

Rank: 87 out of 336

$701K Total Retail Price of All Prescriptions

Rank: 92 out of 336

504 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 504 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

14% of this provider’s 504 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

2% of this provider’s 10,918 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
AMLODIPINE BESYLATE 588 474 1 1
LEVOTHYROXINE SODIUM 439 344 2 7
METFORMIN HCL 420 312 3 8
OMEPRAZOLE 370 293 4 3
LISINOPRIL 355 275 5 6
FUROSEMIDE 352 297 6 4
SIMVASTATIN 336 291 7 5
PRAVASTATIN SODIUM 335 281 8 10
METOPROLOL TARTRATE 278 235 9 16
ATORVASTATIN CALCIUM 273 255 10 14
LOSARTAN POTASSIUM 250 223 11 22
MELOXICAM 249 198 12 19
POTASSIUM CHLORIDE 242 193 13 9
HYDROCODONE-ACETAMINOPHEN 227 187 S3 14 2
KLOR-CON 10 217 182 15 75
LISINOPRIL-HYDROCHLOROTHIAZIDE 185 145 16 23
METOPROLOL SUCCINATE 167 133 17 15
GABAPENTIN 164 122 18 11
CLOPIDOGREL 154 133 19 28
LOSARTAN-HYDROCHLOROTHIAZIDE 144 119 20 45
ATENOLOL 142 135 21 26
KLOR-CON M20 137 109 22 51
TRIAMTERENE-HCTZ 136 87 23 35
DOXAZOSIN MESYLATE 135 74 24 86
TRAMADOL HCL 132 104 25 20
PANTOPRAZOLE SODIUM 129 120 26 40
LOVASTATIN 127 110 27 34
ALLOPURINOL 121 106 28 30
TAMSULOSIN HCL 112 106 29 38
PLAVIX 111 99 30 37
WARFARIN SODIUM 110 94 31 17
CARVEDILOL 109 63 32 13
AMITRIPTYLINE HCL 107 56 R 33 57
GLIPIZIDE ER 105 90 34 91
CIPROFLOXACIN HCL 104 79 35 55
NEXIUM 103 75 36 24
RAMIPRIL 99 86 37 84
AZITHROMYCIN 97 74 38 58
DIOVAN 90 74 39 31
CITALOPRAM HBR 85 77 40 21
CLONIDINE HCL 82 66 41 32
HYDRALAZINE HCL 81 68 42 53
BACLOFEN 81 37 42 179
CRESTOR 80 55 44 25
GLIPIZIDE 80 59 44 71
CYCLOBENZAPRINE HCL 77 24 R 46 65
HYDROCHLOROTHIAZIDE 75 74 47 12
FLUOXETINE HCL 74 66 48 81
CYMBALTA 74 30 48 52
METOCLOPRAMIDE HCL 73 52 50 123
ESTRADIOL 71 59 R 51 129
INSULIN SYRINGE 71 45 51 102
MECLIZINE HCL 70 66 53 96
ALENDRONATE SODIUM 68 56 54 54
FENOFIBRATE 67 49 55 72
DOXYCYCLINE HYCLATE 67 44 55 92
NADOLOL 64 38 57 218
DILTIAZEM 24HR CD 64 64 57 126
SERTRALINE HCL 63 38 59 33
SPIRONOLACTONE 63 47 59 42
PAROXETINE HCL 61 41 61 64
FAMOTIDINE 60 48 62 73
LANTUS SOLOSTAR 60 41 62 124
NAPROXEN 58 41 64 80
GLIPIZIDE XL 54 45 65 174
ADVAIR DISKUS 54 29 65 82
CELEBREX 54 36 65 105
ROPINIROLE HCL 53 38 68 98
INDAPAMIDE 53 40 68 160
DONEPEZIL HCL 51 46 70 27
ISOSORBIDE MONONITRATE ER 51 47 70 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 24, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.